The latest price target for NAYA Biosciences (NASDAQ:NAYA) was reported by Maxim Group on January 23, 2025. The analyst firm set a price target for $2.00 expecting NAYA to rise to within 12 months (a possible 414.27% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for NAYA Biosciences (NASDAQ:NAYA) was provided by Maxim Group, and NAYA Biosciences upgraded their buy rating.

The last upgrade for NAYA Biosciences happened on January 23, 2025 when Maxim Group raised their price target to $2. Maxim Group previously had a hold for NAYA Biosciences.

There is no last downgrade for NAYA Biosciences.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NAYA Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NAYA Biosciences was filed on January 23, 2025 so you should expect the next rating to be made available sometime around January 23, 2026.

While ratings are subjective and will change, the latest NAYA Biosciences (NAYA) rating was a upgraded with a price target of $0.00 to $2.00. The current price NAYA Biosciences (NAYA) is trading at is $0.39, which is within the analyst’s predicted range.